Related Experiment Video
Updated: May 6, 2026

Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence
Published on: December 30, 2025
Akt-p53-miR-365-cyclin D1/cdc25A axis contributes to gastric tumorigenesis induced by PTEN deficiency
Shui-Long Guo1, Hui Ye, Yan Teng
11] State Key Laboratory of Proteomics, Genetic Laboratory of Development and Disease, Institute of Biotechnology, Beijing 100071, China [2] Institute of Geriatrics, PLA Postgraduate School of Medicine, PLA General Hospital, Beijing 100853, China [3].
Abstract:
Although PTEN/Akt signaling is frequently deregulated in human gastric cancers, the in vivo causal link between its dysregulation and gastric tumorigenesis has not been established. Here we show that inactivation of PTEN in mouse gastric epithelium initiates spontaneous carcinogenesis with complete penetrance by 2 months of age. Mechanistically, activation of Akt suppresses the abundance of p53, leading to decreased transcription of miR-365, thus causing upregulation of cyclin D1 and cdc25A, which promotes gastric cell proliferation. Importantly, genetic ablation of Akt1 restores miR-365 expression and effectively rescues gastric tumorigenesis in PTEN-mutant mice. Moreover, orthotopic restoration of miR-365 represses PTEN-deficient-induced hyperplasia. In human gastric cancer tissues, miR-365 reduction correlates with poorly differentiated histology, deep invasion and advanced stage, as well as the deregulation of PTEN, phosphorylated Akt, p53, cyclin D1 and cdc25A. These data demonstrate that the PTEN-Akt-p53-miR-365-cyclin D1/cdc25A axis serves as a new mechanism underlying gastric tumorigenesis, providing potential new therapeutic targets.
Insights
Inactivating PTEN in mouse stomachs causes cancer by disrupting the p53-miR-365 pathway, increasing cell proliferation. Restoring miR-365 or Akt1 stops this gastric tumorigenesis.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- PTEN/Akt signaling is often altered in human gastric cancers.
- The direct role of PTEN/Akt dysregulation in gastric tumor development in vivo is unclear.
Purpose of the Study:
- To investigate the in vivo causal link between PTEN/Akt signaling dysregulation and gastric tumorigenesis.
- To elucidate the molecular mechanisms driving gastric cancer initiation and progression in response to PTEN loss.
Main Methods:
- Inactivation of PTEN in mouse gastric epithelium.
- Genetic ablation of Akt1 in PTEN-mutant mice.
- Orthotopic restoration of miR-365.
- Analysis of human gastric cancer tissues.
Main Results:
- PTEN inactivation in mouse gastric epithelium led to spontaneous gastric carcinogenesis.
- Akt activation suppressed p53, decreasing miR-365 and upregulating cyclin D1/cdc25A, promoting proliferation.
- Genetic ablation of Akt1 or miR-365 restoration rescued tumorigenesis in PTEN-mutant mice.
- Reduced miR-365 correlated with advanced human gastric cancer features and pathway deregulation.
Conclusions:
- The PTEN-Akt-p53-miR-365-cyclin D1/cdc25A axis is a novel mechanism in gastric tumorigenesis.
- This pathway represents potential therapeutic targets for gastric cancer treatment.
Related Concept Videos
Abnormal Proliferation
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle
Inhibition of Cdk Activity
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...

